**Clinical Trial Results:** Positive or negative data from PBYI's clinical trials significantly impacts stock price. Successful trials typically boost the price, while failures can lead to declines.

**Regulatory Approvals:** FDA approval or rejection of PBYI's drug candidates is a major driver. Approval usually causes a price surge, while rejection has the opposite effect.

**Market Sentiment:** Overall market trends and investor sentiment towards the biotechnology sector influence PBYI's stock. Bullish sentiment can lift the price, while bearish sentiment can depress it.

**Competition:** The competitive landscape in the markets PBYI operates in affects its stock price. New competitors or superior products from existing rivals can negatively impact the price.

**Financial Performance:** PBYI's cash position, revenue, and profitability (or lack thereof) are key factors. Strong financials can increase investor confidence and drive the price up.

**Partnerships and Collaborations:** Deals with other pharmaceutical companies or research institutions can positively affect the price, signaling validation of PBYI's technology.

**News and Announcements:** Major news events, such as acquisitions, licensing agreements, or key personnel changes, can cause price fluctuations.

**Economic Conditions:** Broader economic factors like interest rates, inflation, and economic growth can indirectly influence investor sentiment and PBYI's stock price.

**Analyst Ratings:** Recommendations from financial analysts can influence investor decisions and affect the stock price. Positive ratings often lead to increased buying pressure.

**Patent Protection:** The strength and breadth of PBYI's patent portfolio are important for maintaining market exclusivity and can support a higher stock price.